| Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ... International journal of antimicrobial agents 56 (1), 105949, 2020 | 6528 | 2020 |
| Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards B La Scola, M Le Bideau, J Andreani, VT Hoang, C Grimaldier, P Colson, ... European Journal of Clinical Microbiology & Infectious Diseases 39 (6), 1059 …, 2020 | 970 | 2020 |
| Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study P Gautret, JC Lagier, P Parola, L Meddeb, J Sevestre, M Mailhe, ... Travel medicine and infectious disease 34, 101663, 2020 | 921 | 2020 |
| Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France M Million, JC Lagier, P Gautret, P Colson, PE Fournier, S Amrane, ... Travel medicine and infectious disease 35, 101738, 2020 | 569 | 2020 |
| Hajj: infectious disease surveillance and control ZA Memish, A Zumla, RF Alhakeem, A Assiri, A Turkestani, KD Al Harby, ... The Lancet 383 (9934), 2073-2082, 2014 | 355 | 2014 |
| Global perspectives for prevention of infectious diseases associated with mass gatherings I Abubakar, P Gautret, GW Brunette, L Blumberg, D Johnson, G Poumerol, ... The Lancet infectious diseases 12 (1), 66-74, 2012 | 327 | 2012 |
| Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis JC Lagier, M Million, P Gautret, P Colson, S Cortaredona, ... Travel medicine and infectious disease 36, 101791, 2020 | 300 | 2020 |
| Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation P Schlagenhauf, L Weld, A Goorhuis, P Gautret, R Weber, ... The Lancet Infectious Diseases 15 (1), 55-64, 2015 | 296 | 2015 |
| Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects A Zumla, JA Al-Tawfiq, VI Enne, M Kidd, C Drosten, J Breuer, MA Muller, ... The Lancet Infectious Diseases 14 (11), 1123-1135, 2014 | 205 | 2014 |
| Natural history of COVID-19 and therapeutic options P Gautret, M Million, PA Jarrot, L Camoin-Jau, P Colson, F Fenollar, ... Expert review of clinical immunology 16 (12), 1159-1184, 2020 | 194 | 2020 |
| Travel and migration associated infectious diseases morbidity in Europe, 2008 V Field, P Gautret, P Schlagenhauf, GD Burchard, E Caumes, ... BMC Infectious Diseases 10, 1-12, 2010 | 186 | 2010 |
| Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network AK Boggild, F Castelli, P Gautret, J Torresi, F von Sonnenburg, ED Barnett, ... Vaccine 28 (46), 7389-7395, 2010 | 166 | 2010 |
| Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review TL Dao, VT Hoang, P Gautret European Journal of Clinical Microbiology & Infectious Diseases 40, 13-25, 2021 | 165 | 2021 |
| Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe P Gautret, P Schlagenhauf, J Gaudart, F Castelli, P Brouqui, ... Emerging infectious diseases 15 (11), 1783, 2009 | 161 | 2009 |
| Nosocomial transmission of measles: an updated review E Botelho-Nevers, P Gautret, R Biellik, P Brouqui Vaccine 30 (27), 3996-4001, 2012 | 156 | 2012 |
| Surveillance for emerging respiratory viruses JA Al-Tawfiq, A Zumla, P Gautret, GC Gray, DS Hui, AA Al-Rabeeah, ... The Lancet infectious diseases 14 (10), 992-1000, 2014 | 150 | 2014 |
| Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010 P Gautret, JP Cramer, V Field, E Caumes, M Jensenius, ... Eurosurveillance 17 (26), 20205, 2012 | 141 | 2012 |
| Mass gathering and globalization of respiratory pathogens during the 2013 Hajj ZA Memish, A Assiri, A Turkestani, S Yezli, M Al Masri, R Charrel, T Drali, ... Clinical Microbiology and Infection 21 (6), 571. e1-571. e8, 2015 | 138 | 2015 |
| Respiratory viruses and bacteria among pilgrims during the 2013 Hajj S Benkouiten, R Charrel, K Belhouchat, T Drali, A Nougairede, N Salez, ... Emerging infectious diseases 20 (11), 1821, 2014 | 138 | 2014 |
| Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France,-January 31st to March … S Amrane, H Tissot-Dupont, B Doudier, C Eldin, M Hocquart, M Mailhe, ... Travel medicine and infectious disease 36, 101632, 2020 | 133 | 2020 |
